You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Siltuximab

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Polycythemia Vera, Primary Myelofibrosis Trial (procedure, other, biological)

Withdrawn
  • Myelofibrosis
  • +3 more
  • Bone Marrow Aspiration and Biopsy
  • +2 more
  • (no location specified)
Oct 21, 2016

Myeloma Trial in Houston (Lenalidomide, Bortezomib, Siltuximab)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 2, 2015

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Plasma Cell Tumor Trial in Belgium, Russian Federation,

Completed
  • Monoclonal Gammopathy of Undetermined Significance
  • +2 more
  • Siltuximab
  • Chicago, Illinois
  • +7 more
Jan 16, 2015

Healthy Trial in Lincoln, Neptune (CNTO 328 (Sp2/0-derived), CNTO 328 (CHO-derived), Placebo)

Completed
  • Healthy
  • CNTO 328 (Sp2/0-derived)
  • +2 more
  • Lincoln, Nebraska
  • +1 more
Feb 4, 2015

Myelodysplastic Syndrome Trial in Worldwide (Siltuximab, Placebo, Best supportive care (BSC))

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Siltuximab
  • +2 more
  • Tampa, Florida
  • +22 more
Sep 24, 2014

Multiple Myeloma Trial in Worldwide (Siltuximab11 mg/kg, Siltuximab 8.3 mg/kg or 11 mg/kg, Velcade (bortezomib))

Completed
Has Results
  • Multiple Myeloma
  • Siltuximab11 mg/kg
  • +4 more
  • Boston, Massachusetts
  • +36 more
Nov 17, 2014

Ovarian Tumors, Pancreatic Tumors, Colorectal Tumors Trial in Worldwide (CNTO 328; Anti-interleukin-6 mAb)

Completed
  • Ovarian Neoplasms
  • +4 more
  • CNTO 328; Anti-interleukin-6 monoclonal antibody
  • Philadelphia, Pennsylvania
  • +11 more
May 13, 2014

Cancer, Prostate Trial in Worldwide (Mitoxantrone, Siltuximab, Prednisone)

Terminated
Has Results
  • Cancer, Prostate
  • Norwalk, Connecticut
  • +35 more
Aug 18, 2014

Multiple Myeloma Trial in Japan (Siltuximab)

Terminated
  • Multiple Myeloma
  • Siltuximab
  • Isehara, Japan
  • +4 more
May 16, 2014

Multiple Myeloma Trial in Netherlands, United States (Siltuximab, Dexamethasone)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +12 more
May 13, 2014

Angioplasty, Transluminal, Percutaneous Coronary Trial (Placebo, Heparin, Abciximab)

Completed
  • Angioplasty, Transluminal, Percutaneous Coronary
  • Placebo
  • +2 more
  • (no location specified)
May 22, 2015

Carcinoma, Renal Cell Trial in Worldwide (CNTO 328)

Completed
  • Carcinoma, Renal Cell
  • CNTO 328
  • Brno, Czech Republic
  • +13 more
Jul 1, 2014

Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia Trial in United States (CNTO 328)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • CNTO 328
  • Little Rock, Arkansas
  • +8 more
Jun 30, 2014

Prostatic Tumors Trial in United States (CNTO 328, Docetaxel)

Completed
  • Prostatic Neoplasms
  • Baltimore, Maryland
  • +4 more
May 23, 2014

Multiple Myeloma Trial in Worldwide (Placebo, Velcade and dexamethasone, Siltuximab, Velcade and dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Placebo, Velcade and dexamethasone
  • Siltuximab, Velcade and dexamethasone
  • Iowa City, Iowa
  • +48 more
Jan 25, 2013

Kidney Cancer Trial (CNTO 328)

Withdrawn
  • Kidney Cancer
  • CNTO 328
  • (no location specified)
Feb 19, 2013

Prostate Cancer Trial in United States (CNTO 328)

Completed
Has Results
  • Prostate Cancer
  • CNTO 328
  • Anniston, Alabama
  • +122 more
Jan 2, 2013